| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8733751 | Critical Reviews in Oncology/Hematology | 2017 | 9 Pages |
Abstract
The WHO glioma classification defines a diffuse midline glioma with a H3-K27M-mutation, and we expect increase of tissue confirmation of DIPG, which will give us the biological information helping the development of a targeted therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Ho-Shin Gwak, Hyeon Jin Park,